Healthcare regulation company Frier Levitt has analyzed FDA enforcement steps versus “investigate only” peptide vendors. Their summary: the FDA considers an item’s classification based upon its supposed use, not its disclaimers. When Web sites incorporate dosage guides, reconstitution Directions, or